Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

NCT02896829 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT02896829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02896829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
April 3, 2013
Completion date
April 30, 2019
Enrollment
97 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia